doi: 10.1172/JCI118990 512 Cabral-MarquesOMarquesAGiilLMDe VitoRRademacherJGntherJet al
ContractLaboratory.com connects nasal spray manufacturers, generic drug companies, contract development and manufacturing organizations (CDMOs), and regulatory consultants with accredited pharmaceutical testing laboratories and pharmacology and drug development specialists equipped for OINDP testing
Key Regulatory Points as of 2026: Not FDA-approved for any medical indication Cannot legally be sold as a drug, food, or dietary supplement for human consumption Legally sold as a "research chemical," not intended for human use Not a DEA-scheduled substance, so possession is not illegal (unlike anabolic steroids) Many medical clinics offer BPC-157 treatments despite lack of approval The FDA has expressed safety concerns due to the lack of human clinical trial data and the potential for adverse effects from unregulated manufacturing
BPC-157 and TB-500 are unapproved experimental drugs
On the other hand, despite sCT-induced neuronal activation in the AP of RAMP 1/3 KO HFD-fed mice, it did not result in an anorectic effect on day 1 of treatment suggesting the necessity of AMY 1 R and AMY 3 R to induce anorexia and that this circuitry is independent of signalling at the core CTR receptor